Lower exhaled nitric oxide in infants with Cystic Fibrosis compared to healthy controls.

作者: Insa Korten , Margot Liechti , Florian Singer , Gaudenz Hafen , Isabelle Rochat

DOI: 10.1016/J.JCF.2017.05.005

关键词: In patientAirwayMedicineCystic fibrosisBiomarker (medicine)ImmunologyExhaled nitric oxideInflammationCystic fibrosis transmembrane conductance regulator

摘要: Exhaled nitric oxide (FENO) is a well-known, non-invasive airway biomarker. In patients with Cystic Fibrosis (CF) FENO decreased. To understand if reduced primary related to Transmembrane Conductance Regulator (CFTR) dysfunction or an epiphenomenon of chronic inflammation, we measured in 34 infants CF prior clinical symptoms and 68 healthy controls. was lower compared controls (p=0.0006) the effect more pronounced without residual CFTR function (p<0.0001). This suggests that early life, possibly associated underlying dysfunction.

参考文章(21)
D Szolar, K Preidler, G Ranner, H Braun, C Kugler, G Wolf, H Stammberger, F Ebner, The sphenoid sinus during childhood: establishment of normal developmental standards by MRI Surgical and Radiologic Anatomy. ,vol. 16, pp. 193- 198 ,(1994) , 10.1007/BF01627594
Hartmut Grasemann, Tanja Gonska, Julie Avolio, Michelle Klingel, Elizabeth Tullis, Felix Ratjen, Effect of ivacaftor therapy on exhaled nitric oxide in patients with cystic fibrosis Journal of Cystic Fibrosis. ,vol. 14, pp. 727- 732 ,(2015) , 10.1016/J.JCF.2015.07.001
Kavitha Kotha, Rhonda D. Szczesniak, Anjaparavanda P. Naren, Matthew C. Fenchel, Leo L. Duan, Gary L. McPhail, John P. Clancy, Concentration of fractional excretion of nitric oxide (FENO): A potential airway biomarker of restored CFTR function. Journal of Cystic Fibrosis. ,vol. 14, pp. 733- 740 ,(2015) , 10.1016/J.JCF.2015.07.002
Hartmut Grasemann, Raphael Schwiertz, Corinna Grasemann, Udo Vester, Kurt Racké, Felix Ratjen, Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis Respiratory Research. ,vol. 7, pp. 87- 87 ,(2006) , 10.1186/1465-9921-7-87
Andrei Malinovschi, Dora Ludviksdottir, Ellen Tufvesson, Giovanni Rolla, Leif Bjermer, Kjell Alving, Zuzana Diamant, Application of nitric oxide measurements in clinical conditions beyond asthma. European Clinical Respiratory Journal. ,vol. 2, pp. 28517- 28517 ,(2015) , 10.3402/ECRJ.V2.28517
BENJAMIN GASTON, FELIX RATJEN, JOHN W. VAUGHAN, NEIL R. MALHOTRA, ROBERT G. CANADY, ASHLEY H. SNYDER, JOHN F. HUNT, SEBASTIAN GAERTIG, JOANNA B. GOLDBERG, Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. American Journal of Respiratory and Critical Care Medicine. ,vol. 165, pp. 387- 390 ,(2002) , 10.1164/AJRCCM.165.3.2106006
U. Frey, J. Stocks, P. Sly, J. Bates, o.b.o.t.E.T.F.o.S.f. Infant Respiratory Function Testing, Specifications for signal processing and data handling used for infant pulmonary function testing European Respiratory Journal. ,vol. 16, pp. 1016- 1022 ,(2000) , 10.1183/09031936.00.16510160
Wendy K. Steagall, Heather L. Elmer, Kristine G. Brady, Thomas J. Kelley, Cystic Fibrosis Transmembrane Conductance Regulator-Dependent Regulation of Epithelial Inducible Nitric Oxide Synthase Expression American Journal of Respiratory Cell and Molecular Biology. ,vol. 22, pp. 45- 50 ,(2000) , 10.1165/AJRCMB.22.1.3789
Karin M. de Winter-de Groot, Cornelis K. van der Ent, Nitric oxide in cystic fibrosis. Journal of Cystic Fibrosis. ,vol. 4, pp. 25- 29 ,(2005) , 10.1016/J.JCF.2005.05.008
Hartmut Grasemann, Darakhshanda Shehnaz, Masahiro Enomoto, Michael Leadley, Jaques Belik, Felix Ratjen, L-Ornithine Derived Polyamines in Cystic Fibrosis Airways PLoS ONE. ,vol. 7, pp. e46618- ,(2012) , 10.1371/JOURNAL.PONE.0046618